Editorial
| Rev Diabet Stud,
2004,
1(4):156-164 |
DOI 10.1900/RDS.2004.1.156 |
Differential Roles of Costimulatory Signaling Pathways in Type 1 Diabetes Mellitus
Bernhard O. Boehm1, Jeffrey A. Bluestone2
1Division of Endocrinology and Diabetes, Department of Internal Medicine, University of Ulm, Germany
2Diabetes Center, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Address correspondence to: Bernhard O. Boehm, e-mail: bernhard.boehm@medizin.uni-ulm.de
Abstract
n/a
Fulltext:
 HTML
,  PDF
(336KB)
This article has been cited by other articles:
|
A proinsulin74-90-derived protease-resistant, altered peptide ligand increases TGF-beta1 secretion in PBMC from patients with type 1 diabetes mellitus
van Aalst D, Kalbacher H, Palesch D, Zou F, Spyrantis A, Rosinger S, Boehm BO, Burster T
J Leukoc Biol 2010. 87(5):943-948
|
|
|
Protease-resistant human GAD-derived altered peptide ligands decrease TNF-alpha and IL-17 production in peripheral blood cells from patients with type 1 diabetes mellitus
Boehm BO, Rosinger S, Sauer G, Manfras BJ, Palesch D, Schiekofer S, Kalbacher H, Burster T
Mol Immunol 2009. 46(13):2576-2584
|
|
|
Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes
Endl J, Rosinger S, Schwarz B, Friedrich SO, Rothe G, Karges W, Schlosser M, Eiermann T, Schendel DJ, Boehm BO
Diabetes 2006. 55(1):50-60
|
|
|
Genetic Susceptibility to Type 1 Diabetes in the Intracellular Pathway of Antigen Processing – A Subject Review and Cross-Study Comparison
Sia C, Weinem M
Rev Diabet Stud 2005. 2(1):40-52
|
|
|
The Role of Regulatory T Cell Defects in Type I Diabetes and the Potential of these Cells for Therapy
Thomas D, Zaccone P, Cooke A
Rev Diabet Stud 2005. 2(1):9-18
|
|
|
